Tomiko T. Oskotsky

Prof. Dr. Tomiko T. Oskotsky

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 October 2021 in Nature Aging
Verified
Journal Article
Closed access
PDF file
ATAlice Taubes
Alice Taubes
PNPhil Nova
Phil Nova
KZKelly A. Zalocusky
Kelly A. Zalocusky
IKIdit Kosti
Idit Kosti
MBMesude Bicak
Mesude Bicak
YHYadong Huang
Yadong Huang

4 July 2024 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
ATAlice S. Tang
Alice S. Tang
SWSarah R. Woldemariam
Sarah R. Woldemariam
SMSilvia Miramontes
Silvia Miramontes
BNBeau Norgeot
Beau Norgeot
TOTomiko T. Oskotsky
Tomiko T. Oskotsky
MSMarina Sirota
Marina Sirota

29 August 2023 in The FASEB Journal
Verified
Journal Article
Open access
LGLinda C. Giudice
Linda C. Giudice
TOTomiko T. Oskotsky
Tomiko T. Oskotsky
SFSimileoluwa Falako
Simileoluwa Falako
JOJessica Opoku‐Anane
Jessica Opoku‐Anane
MSMarina Sirota
Marina Sirota
Endometriosis is a common estrogen‐dependent disorder wherein uterine lining tissue (endometrium) is found mainly in the pelvis where it causes inflammation, chronic pelvic pain, pain with intercourse and menses, and infertility. Recent evidence also supports a systemic inflammatory component that underlies associated co‐morbidities, e.g., migraines and cardiovascular and autoimmune diseases. Genetics and environment contribute significantly to disease risk, and with the explosion of omics technologies, underlying mechanisms of symptoms are increasingly being elucidated, although novel and effective therapeutics for pain and infertility have lagged behind these advances. Moreover, there are stark disparities in diagnosis, access to care, and treatment among persons of color and transgender/nonbinary identity, socioeconomically disadvantaged populations, and adolescents, and a disturbing low awareness among health care providers, policymakers, and the lay public about endometriosis, which, if left undiagnosed and under‐treated can lead to significant fibrosis, infertility, depression, and markedly diminished quality of life. This review summarizes endometriosis epidemiology, compelling evidence for its pathogenesis, mechanisms underlying its pathophysiology in the age of precision medicine, recent biomarker discovery, novel therapeutic approaches, and issues around reproductive justice for marginalized populations with this disorder spanning the past 100 years. As we enter the next revolution in health care and biomedical research, with rich molecular and clinical datasets, single‐cell omics, and population‐level data, endometriosis is well positioned to benefit from data‐driven research leveraging computational and artificial intelligence approaches integrating data and predicting disease risk, diagnosis, response to medical and surgical therapies, and prognosis for recurrence.

21 February 2024 in Nature Aging
Verified
Journal Article
Open access
PDF file
ATAlice S. Tang
Alice S. Tang
KRKatherine P. Rankin
Katherine P. Rankin
GCGabriel Cerono
Gabriel Cerono
SMSilvia Miramontes
Silvia Miramontes
HMHunter Mills
Hunter Mills
MSMarina Sirota
Marina Sirota
Identification of Alzheimer’s disease (AD) onset risk can facilitate interventions before irreversible disease progression. We demonstrate that electronic health records from the University of California, San Francisco, followed by knowledge networks (for example, SPOKE) allow for (1) prediction of AD onset and (2) prioritization of biological hypotheses, and (3) contextualization of sex dimorphism. We trained random forest models and predicted AD onset on a cohort of 749 individuals with AD and 250,545 controls with a mean area under the receiver operating characteristic of 0.72 (7 years prior) to 0.81 (1 day prior). We further harnessed matched cohort models to identify conditions with predictive power before AD onset. Knowledge networks highlight shared genes between multiple top predictors and AD (for example, APOE, ACTB, IL6 and INS). Genetic colocalization analysis supports AD association with hyperlipidemia at the APOE locus, as well as a stronger female AD association with osteoporosis at a locus near MS4A6A. We therefore show how clinical data can be utilized for early AD prediction and identification of personalized biological hypotheses.

20 October 2021 in Molecular Neurobiology
Verified
Journal Article
Open access
PDF file
SBStella A. Belonwu
Stella A. Belonwu
YLYaqiao Li
Yaqiao Li
DBDaniel Bunis
Daniel Bunis
ARArjun Arkal Rao
Arjun Arkal Rao
CSCaroline Warly Solsberg
Caroline Warly Solsberg
MSMarina Sirota
Marina Sirota
Alzheimer’s disease (AD) is a pervasive neurodegenerative disorder that disproportionately affects women. Since neural anatomy and disease pathophysiology differ by sex, investigating sex-specific mechanisms in AD pathophysiology can inform new therapeutic approaches for both sexes. Previous bulk human brain RNA sequencing studies have revealed sex differences in dysregulated molecular pathways related to energy production, neuronal function, and immune response; however, the sex differences in disease mechanisms are yet to be examined comprehensively on a single-cell level. We leveraged nearly 74,000 cells from human prefrontal and entorhinal cortex samples from the first two publicly available single-cell RNA sequencing AD datasets to perform a case versus control sex-stratified differential gene expression analysis and pathway network enrichment in a cell type-specific manner for each brain region. Our examination at the single-cell level revealed sex differences in AD prominently in glial cells of the prefrontal cortex. In the entorhinal cortex, we observed the same genes and networks to be perturbed in opposing directions between sexes in AD relative to healthy state. Our findings contribute to growing evidence of sex differences in AD-related transcriptomic changes, which can fuel the development of therapies that may prove more effective at reversing AD pathophysiology.

21 December 2023 in Cell Reports Medicine
Verified
Journal Article
Open access
JGJonathan L. Golob
Jonathan L. Golob
TOTomiko T. Oskotsky
Tomiko T. Oskotsky
ATAlice S. Tang
Alice S. Tang
ARAlennie Roldan
Alennie Roldan
VCVerena Chung
Verena Chung
MSMarina Sirota
Marina Sirota
Every year, 11% of infants are born preterm with significant health consequences, with the vaginal microbiome a risk factor for preterm birth. We crowdsource models to predict (1) preterm birth (PTB; <37 weeks) or (2) early preterm birth (ePTB; <32 weeks) from 9 vaginal microbiome studies representing 3,578 samples from 1,268 pregnant individuals, aggregated from public raw data via phylogenetic harmonization. The predictive models are validated on two independent unpublished datasets representing 331 samples from 148 pregnant individuals. The top-performing models (among 148 and 121 submissions from 318 teams) achieve area under the receiver operator characteristic (AUROC) curve scores of 0.69 and 0.87 predicting PTB and ePTB, respectively. Alpha diversity, VALENCIA community state types, and composition are important features in the top-performing models, most of which are tree-based methods. This work is a model for translation of microbiome data into clinically relevant predictive models and to better understand preterm birth.